Table of Content

1 Preface

2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Key Industry Trends

5 Global Vascular Stents Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Breakup by Product Type
5.5 Market Breakup by Material
5.6 Market Breakup by Mode of Delivery
5.7 Market Breakup by End-User
5.8 Market Breakup by Region
5.9 Market Forecast

6 Market Breakup by Product Type
6.1 Coronary Stents
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Peripheral Vascular Stents
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Evar Stent Grafts
6.3.1 Market Trends
6.3.2 Market Forecast

7 Market Breakup by Material
7.1 Metallic Stents
7.1.1 Market Trends
7.1.2 Market Breakup by Type
7.1.2.1 Cobalt Chromium
7.1.2.1.1 Market Trends
7.1.2.1.2 Market Forecast
7.1.2.2 Platinum Chromium
7.1.2.2.1 Market Trends
7.1.2.2.2 Market Forecast
7.1.2.3 Nickel Titanium
7.1.2.3.1 Market Trends
7.1.2.3.2 Market Forecast
7.1.2.4 Stainless Steel
7.1.2.4.1 Market Trends
7.1.2.4.2 Market Forecast
7.1.3 Market Forecast
7.2 Others
7.2.1 Market Trends
7.2.2 Market Forecast

8 Market Breakup by Mode of Delivery
8.1 Balloon-Expandable Stents
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Self-Expanding Stents
8.2.1 Market Trends
8.2.2 Market Forecast

9 Market Breakup by End-User
9.1 Hospitals and Cardiac Centers
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Ambulatory Surgical Centers
9.2.1 Market Trends
9.2.2 Market Forecast

10 Market Breakup by Region
10.1 North America
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Europe
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Asia Pacific
10.3.1 Market Trends
10.3.2 Market Forecast
10.4 Middle East and Africa
10.4.1 Market Trends
10.4.2 Market Forecast
10.5 Latin America
10.5.1 Market Trends
10.5.2 Market Forecast

11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes

14 Price Analysis
14.1 Price Indicators
14.2 Price Structure
14.3 Margin Analysis

15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Medtronic Plc
15.3.2 Abbott Laboratories
15.3.3 Boston Scientific Corporation
15.3.4 Biotronik Se & Co. Kg
15.3.5 Braun Melsungen Ag
15.3.6 Terumo Corporation
15.3.7 Microport Scientific Corporation
15.3.8 Meril Life Sciences Pvt. Ltd.
15.3.9 Vascular Concepts Limited
15.3.10 C.R. Bard, Inc.
15.3.11 W.L. Gore and Associates, Inc.
15.3.12 Endologix, Inc.
15.3.13 Lombard Medical
15.3.14 Translumina Gmbh
15.3.15 Jotec Gmbh